Clinical: Multiple Myeloma  AJMC.com Managed Markets Network

ELOQUENT-3: Adding Elotuzumab to Pomalidomide, Dexamethasone Improves PFS in R/R Multiple Myeloma. David Bai, PharmD. ELOQUENT-3 trial results …

X